The FDA under Marks is Chemist Warehouse in the US.
Cynata should do their trials with WHO.
Cynata is in the process of doing its first P3 ever and it’s not with the FDA. Cynata is one third enrolled for its first ever trial with the FDA - a 60 candidate P2.
SI has completed multiple FDA trials and many of them successfully (multiple P2s successfully) and achieved FDA approval for one.
A Cynata shareholder throwing shade on SI over trials, really doesn’t make a lot of sense. It’s ridiculous actually and reflects poorly on you for trying.
You’re bitter about the outcome. You were wrong.
SI and MSB are world leading pioneers in MSCs. Cynata are not even in the conversation. They are a long way behind.
You have to recognise and deal with it. Or not.
Maybe Cynata is too good for FDA approval. That’s what you are trying to convince yourself of. Really?
CYP Price at posting:
22.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)